Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples